scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)

Q: What does CUSIP 810648105 represent in this 13F holders report?

CUSIP 810648105 is the security identifier for SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share in Q3 2018?

31 institutional investors reported SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share for Q3 2018. Use the holders table for investor-level position and value details.

CUSIP: 810648105

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 53,364,241
Total 13F shares: 8,056,307
Share change: -36,176
Total reported value: $47,291,256
Price per share: $5.87
Number of holders: 31
Value change: -$192,971
Number of buys: 14
Number of sells: 13

Quarterly Holders Quick Answers

What is CUSIP 810648105?
CUSIP 810648105 identifies SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2018
Previous quarter: Q2 2018

Recent filing periods for CUSIP 810648105:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	6.4%	3,409,865	$19,300,000	—	30 Jun 2018	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	5.4%	2,857,143	$16,171,000	—	30 Jun 2018	13F
AWM Investment Company, Inc.	13F	Company	0.76%	405,807	$2,297,000	—	30 Jun 2018	13F
BlackRock Finance, Inc.	13F	Company	0.65%	348,086	$1,970,000	—	30 Jun 2018	13F
Alyeska Investment Group, L.P.	13F	Company	0.43%	230,819	$1,306,000	—	30 Jun 2018	13F
VANGUARD GROUP INC	13F	Company	0.39%	209,258	$1,184,000	—	30 Jun 2018	13F
STATE STREET CORP	13F	Company	0.18%	98,412	$556,000	—	30 Jun 2018	13F
MORGAN STANLEY	13F	Company	0.14%	75,968	$430,000	—	30 Jun 2018	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.13%	69,500	$393,000	—	30 Jun 2018	13F
NORTHERN TRUST CORP	13F	Company	0.13%	67,932	$384,000	—	30 Jun 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.09%	46,801	$264,000	—	30 Jun 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.08%	40,287	$228,000	—	30 Jun 2018	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.06%	29,815	$169,000	—	30 Jun 2018	13F
COLONY GROUP LLC	13F	Company	0.04%	23,209	$131,000	—	30 Jun 2018	13F
ROYAL BANK OF CANADA	13F	Company	0.04%	20,000	$113,000	—	30 Jun 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.04%	19,300	$109,000	—	30 Jun 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.04%	19,082	$108,000	—	30 Jun 2018	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	16,828	$95,000	—	30 Jun 2018	13F
Bank of New York Mellon Corp	13F	Company	0.03%	14,966	$85,000	—	30 Jun 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.03%	13,803	$78,000	—	30 Jun 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.03%	13,400	$76,000	—	30 Jun 2018	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.02%	10,943	$62,000	—	30 Jun 2018	13F
Spark Investment Management LLC	13F	Company	0.02%	10,720	$60,000	—	30 Jun 2018	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	10,410	$59,000	—	30 Jun 2018	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	9,100	$52,000	—	30 Jun 2018	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	4,431	$25,000	—	30 Jun 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	3,490	$20,000	—	30 Jun 2018	13F
CITIGROUP INC	13F	Company	0%	2,503	$14,000	—	30 Jun 2018	13F
UBS Group AG	13F	Company	0%	1,671	$9,000	—	30 Jun 2018	13F
JPMORGAN CHASE & CO	13F	Company	0%	1,656	$9,000	—	30 Jun 2018	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	1,430	$8,000	—	30 Jun 2018	13F
Legal & General Group Plc	13F	Company	0%	1,265	$7,000	—	30 Jun 2018	13F
BESSEMER GROUP INC	13F	Company	0%	1,254	$7,000	—	30 Jun 2018	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0%	727	$4,000	—	30 Jun 2018	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	625	$4,000	—	30 Jun 2018	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	0%	357	$4,000	—	30 Jun 2018	13F
BARCLAYS PLC	13F	Company	0%	718	$3,000	—	30 Jun 2018	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	214	$1,211	—	30 Jun 2018	13F
PIEDMONT INVESTMENT ADVISORS INC	13F	Company	0%	118	$1,000	—	30 Jun 2018	13F

Institutional Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) as of Q3 2018

As of 30 Sep 2018, scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,056,307 shares. The largest 10 holders included ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, LLC, AWM Investment Company, Inc., BlackRock Inc., Alyeska Investment Group, L.P., Vanguard Group Inc, STATE STREET CORP, BRIDGEWAY CAPITAL MANAGEMENT INC, NORTHERN TRUST CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 31 institutional shareholders reporting positions in this security for the Q3 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2018 vs Q2 2018 Across Filers

Q2 2018 holders

Q3 2018 holders

Holder diff

-6

Investor	Q2 2018 Shares	Q3 2018 Shares	Share Diff	Share Chg %	Q2 2018 Value $	Q3 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.